Effect of route of administration and effusions on methotrexate pharmacokinetics.
D000284:Administration, Oral; D001202:Ascitic Fluid; D005260:Female; D006207:Half-Life; D006801:Humans; D007275:Injections, Intravenous; D007700:Kinetics; D008297:Male; D008727:Methotrexate / Q000008:administration & dosage* / Q000097:blood / Q000627:therapeutic use / Q000652:urine; D009362:Neoplasm Metastasis; D009369:Neoplasms / Q000188:drug therapy; D010534:Peritoneal Neoplasms / Q000378:metabolism*; D010996:Pleural Effusion / Q000209:etiology / Q000378:metabolism*; D011485:Protein Binding; D014316:Tritium
D014316:Tritium; D008727:Methotrexate